NCT05421858: An ongoing trial by Basilea Pharmaceutica
This trial is ongoing. It must report results 3 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05421858 |
|---|---|
| Title | An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participants With Candidemia and/or Invasive Candidiasis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 11, 2024 |
| Completion date | Jan. 30, 2028 |
| Required reporting date | Jan. 29, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |